These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15081217)

  • 21. Imperatorin sustained-release tablets: In vitro and pharmacokinetic studies.
    Pan J; Lu W; Li C; Wang S; He L
    Arch Pharm Res; 2010 Aug; 33(8):1209-16. PubMed ID: 20803124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Controlled release calcium silicate based floating granular delivery system of ranitidine hydrochloride.
    Jain AK; Jain SK; Yadav A; Agrawal GP
    Curr Drug Deliv; 2006 Oct; 3(4):367-72. PubMed ID: 17076638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of drug (metoprolol succinate) release by inclusion of hydrophobic polymer in hydrophilic matrix.
    Siddique S; Bose A; Khanam J
    Drug Dev Ind Pharm; 2011 Sep; 37(9):1016-25. PubMed ID: 21401340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Formulation and development of gastroretentive drug delivery system for ofloxacin.
    Ali J; Hasan S; Ali M
    Methods Find Exp Clin Pharmacol; 2006 Sep; 28(7):433-9. PubMed ID: 17003848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of near zero-order release dosage forms using three-dimensional printing (3-DP) technology.
    Wang CC; Tejwani Motwani MR; Roach WJ; Kay JL; Yoo J; Surprenant HL; Monkhouse DC; Pryor TJ
    Drug Dev Ind Pharm; 2006 Mar; 32(3):367-76. PubMed ID: 16556541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Directly compressed mini matrix tablets containing ibuprofen: preparation and evaluation of sustained release.
    Lopes CM; Sousa Lobo JM; Costa P; Pinto JF
    Drug Dev Ind Pharm; 2006 Jan; 32(1):95-106. PubMed ID: 16455608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of water soluble fillers in hydroxypropylmethylcellulose matrices on in vitro and in vivo drug release.
    Sako K; Sawada T; Nakashima H; Yokohama S; Sonobe T
    J Control Release; 2002 May; 81(1-2):165-72. PubMed ID: 11992689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The development of sustained release drug delivery platforms using melt-extruded cellulose-based polymer blends.
    Wilson MR; Jones DS; Andrews GP
    J Pharm Pharmacol; 2017 Jan; 69(1):32-42. PubMed ID: 27747867
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Release Adjustment of Two Drugs with Different Solubility Combined in a Matrix Tablet.
    Chaerunisaa AY; Ali R; Dashevskiy A
    AAPS PharmSciTech; 2019 Mar; 20(4):142. PubMed ID: 30874996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Self-Micro-Emulsifying Controlled Release of Eugenol Pellets: Preparation, In vitro/In vivo Investigation in Beagle Dogs.
    Wang Q; Guo M; Adu-Frimpong M; Zhang K; Yang Q; Toreniyazov E; Ji H; Xu X; Cao X; Yu J
    AAPS PharmSciTech; 2019 Aug; 20(7):284. PubMed ID: 31407165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Production of dosage forms for oral drug delivery by laminar extrusion of wet masses.
    Müllers KC; Wahl MA; Pinto JF
    Eur J Pharm Biopharm; 2013 Aug; 84(3):626-32. PubMed ID: 23403012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro and in vivo evaluation of hydrophilic and hydrophobic polymers-based nicorandil-loaded peroral tablet compared with its once-daily commercial sustained-release tablet.
    Tamilvanan S; Venkatesh Babu R; Nappinai A; Sivaramakrishnan G
    Drug Dev Ind Pharm; 2011 Apr; 37(4):436-45. PubMed ID: 20923389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Controlled drug release from pellets containing water-insoluble drugs dissolved in a self-emulsifying system.
    Serratoni M; Newton M; Booth S; Clarke A
    Eur J Pharm Biopharm; 2007 Jan; 65(1):94-8. PubMed ID: 17056237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bioavailability of ibuprofen from hot-melt extruded mini-matrices.
    De Brabander C; Vervaet C; Van Bortel L; Remon JP
    Int J Pharm; 2004 Mar; 271(1-2):77-84. PubMed ID: 15129975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel approach to sustained pseudoephedrine release: differentially coated mini-tablets in HPMC capsules.
    Ishida M; Abe K; Hashizume M; Kawamura M
    Int J Pharm; 2008 Jul; 359(1-2):46-52. PubMed ID: 18467046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dissolution mechanism of poorly water-soluble drug from extended release solid dispersion system with ethylcellulose and hydroxypropylmethylcellulose.
    Ohara T; Kitamura S; Kitagawa T; Terada K
    Int J Pharm; 2005 Sep; 302(1-2):95-102. PubMed ID: 16102924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimization of sustained-release propranolol dosage form using factorial design and response surface methodology.
    Huang YB; Tsai YH; Yang WC; Chang JS; Wu PC
    Biol Pharm Bull; 2004 Oct; 27(10):1626-9. PubMed ID: 15467208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of a simple method for the preparation of a silica gel based controlled delivery system with a high drug content.
    Ohta KM; Fuji M; Takei T; Chikazawa M
    Eur J Pharm Sci; 2005 Sep; 26(1):87-96. PubMed ID: 15964179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Osmotic pellet system comprising osmotic core and in-process amorphized drug in polymer-surfactant layer for controlled delivery of poorly water-soluble drug.
    Saindane N; Vavia P
    J Pharm Sci; 2012 Sep; 101(9):3169-79. PubMed ID: 22418998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Porous carrier based floating granular delivery system of repaglinide.
    Jain SK; Agrawal GP; Jain NK
    Drug Dev Ind Pharm; 2007 Apr; 33(4):381-91. PubMed ID: 17523003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.